Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

8SE8

HTRA-1 PD/SA bound to CKP 1G10

8SE8 の概要
エントリーDOI10.2210/pdb8se8/pdb
分子名称Serine protease HTRA1, Cysteine knot peptide, SULFATE ION, ... (5 entities in total)
機能のキーワードprotease, cysteine knot peptide, complex, peptide binding protein
由来する生物種Homo sapiens (human)
詳細
タンパク質・核酸の鎖数24
化学式量合計370054.41
構造登録者
Ultsch, M.H. (登録日: 2023-04-08, 公開日: 2024-07-03, 最終更新日: 2025-01-15)
主引用文献Li, Y.,Wei, Y.,Ultsch, M.,Li, W.,Tang, W.,Tombling, B.,Gao, X.,Dimitrova, Y.,Gampe, C.,Fuhrmann, J.,Zhang, Y.,Hannoush, R.N.,Kirchhofer, D.
Cystine-knot peptide inhibitors of HTRA1 bind to a cryptic pocket within the active site region.
Nat Commun, 15:4359-4359, 2024
Cited by
PubMed Abstract: Cystine-knot peptides (CKPs) are naturally occurring peptides that exhibit exceptional chemical and proteolytic stability. We leveraged the CKP carboxypeptidase A1 inhibitor as a scaffold to construct phage-displayed CKP libraries and subsequently screened these collections against HTRA1, a trimeric serine protease implicated in age-related macular degeneration and osteoarthritis. The initial hits were optimized by using affinity maturation strategies to yield highly selective and potent picomolar inhibitors of HTRA1. Crystal structures, coupled with biochemical studies, reveal that the CKPs do not interact in a substrate-like manner but bind to a cryptic pocket at the S1' site region of HTRA1 and abolish catalysis by stabilizing a non-competent active site conformation. The opening and closing of this cryptic pocket is controlled by the gatekeeper residue V221, and its movement is facilitated by the absence of a constraining disulfide bond that is typically present in trypsin fold serine proteases, thereby explaining the remarkable selectivity of the CKPs. Our findings reveal an intriguing mechanism for modulating the activity of HTRA1, and highlight the utility of CKP-based phage display platforms in uncovering potent and selective inhibitors against challenging therapeutic targets.
PubMed: 38777835
DOI: 10.1038/s41467-024-48655-w
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (3.18 Å)
構造検証レポート
Validation report summary of 8se8
検証レポート(詳細版)ダウンロードをダウンロード

235458

件を2025-04-30に公開中

PDB statisticsPDBj update infoContact PDBjnumon